Literature DB >> 63380

Role of epitope density in the induction of tolerance and immunity with thymus-independent antigens. III. Interaction of epitope density and receptor avidity.

C Desaymard, B Pearce, M Feldmann.   

Abstract

The induction of B cell tolerance to 2,4-dinitrophenyl conjugates of polysaccharide antigens (levan or dextran) was studied in mice primed with keyhole limpet hemocyanin (KLH) or 2,4,6-trinitrophenylated KLH. The relationship of the epitope density of the tolerogen with avidity of B cell receptors (as judged indirectly by a plaque inhibition assay) was investigated. It was found that high avidity precursors (IgG) were tolerized by antigen of much lower epitope density, and at lower concentration, than were low avidity precursors (especially IgM cells). IgA cells were intermediate in behavior. These results suggest that the epitope density effect acts by ensuring a necessary degree and/or energy of antigen binding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 63380     DOI: 10.1002/eji.1830060910

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Differential tolerance of thymus-independent and thymus-dependent antibody responses.

Authors:  J P Tite; S Marshall-Clarke; J H Playfair
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

Review 2.  Tolerance, the thymus, and suppressor T cells.

Authors:  B H Waksman
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Cellular and molecular requirements for X-linked, hapten-specific B-cell blockade in CBA/N mice.

Authors:  B Merchant; H Snippe; E F Lizzio; J K Inman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

4.  Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice.

Authors:  M R Szewczuk; G W Siskind
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.